These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1981817)
1. Effects of intracerebroventricular administration of adrenoceptor-agonists on the regulation of renal water and electrolytes handling through endocrine, renal and hemodynamic function. Ota K; Kimura T; Shoji M; Inoue M; Sato K; Ohta M; Yamamoto T; Tsunoda K; Abe K; Yoshinaga K Tohoku J Exp Med; 1990 Sep; 162(1):27-39. PubMed ID: 1981817 [TBL] [Abstract][Full Text] [Related]
2. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion. Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Ohta M; Yoshinaga K Am J Physiol; 1992 Jun; 262(6 Pt 1):E856-62. PubMed ID: 1535483 [TBL] [Abstract][Full Text] [Related]
3. Effects of human atrial natriuretic peptide on renal function and vasopressin release. Kimura T; Abe K; Shoji M; Tsunoda K; Matsui K; Ota K; Inoue M; Yasujima M; Yoshinaga K Am J Physiol; 1986 May; 250(5 Pt 2):R789-94. PubMed ID: 2939732 [TBL] [Abstract][Full Text] [Related]
4. Effects of centrally administered atrial natriuretic peptide on renal functions. Shoji M; Kimura T; Matsui K; Ota K; Iitake K; Inoue M; Yasujima M; Abe K; Yoshinaga K Acta Endocrinol (Copenh); 1987 Aug; 115(4):433-40. PubMed ID: 2957880 [TBL] [Abstract][Full Text] [Related]
5. Interaction of ANP with endothelin on cardiovascular, renal, and endocrine function. Ota K; Kimura T; Shoji M; Inoue M; Sato K; Ohta M; Yamamoto T; Tsunoda K; Abe K; Yoshinaga K Am J Physiol; 1992 Feb; 262(2 Pt 1):E135-41. PubMed ID: 1531732 [TBL] [Abstract][Full Text] [Related]
6. Responses of atrial natriuretic peptide, vasopressin, aldosterone and renal function to intracerebroventricular infusion of angiotensin II in dogs. Shoji M; Kimura T; Ota K; Inoue M; Sato K; Ohta M; Yamamoto T; Abe K; Yoshinaga K Tohoku J Exp Med; 1991 Mar; 163(3):187-97. PubMed ID: 1829554 [TBL] [Abstract][Full Text] [Related]
7. The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats. Ruskoaho H; Leppäluoto J Br J Pharmacol; 1989 May; 97(1):125-32. PubMed ID: 2566350 [TBL] [Abstract][Full Text] [Related]
8. Responses of vasopressin, atrial natriuretic peptide, and blood pressure to central osmotic stimulation. Iitake K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Yamamoto T; Yasujima M; Abe K Am J Physiol; 1989 Oct; 257(4 Pt 1):E611-6. PubMed ID: 2529777 [TBL] [Abstract][Full Text] [Related]
9. Involvement of vasopressin in the cardiovascular effects of intracerebroventricularly administered alpha 1-adrenoceptor agonists in the conscious rat. Hiwatari M; Johnston CI J Hypertens; 1985 Dec; 3(6):613-20. PubMed ID: 2868056 [TBL] [Abstract][Full Text] [Related]
10. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Maack T; Marion DN; Camargo MJ; Kleinert HD; Laragh JH; Vaughan ED; Atlas SA Am J Med; 1984 Dec; 77(6):1069-75. PubMed ID: 6239544 [TBL] [Abstract][Full Text] [Related]
11. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors. Evans RG; Anderson WP Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219 [TBL] [Abstract][Full Text] [Related]
12. Effect of vasopressin on atrial natriuretic peptide release and renal function in dogs. Inoue M; Kimura T; Ota K; Iitake K; Shoji M; Sato K; Ota M; Yoshinaga K Am J Physiol; 1988 Oct; 255(4 Pt 1):E449-55. PubMed ID: 2972212 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers. Bidiville J; Waeber G; Porchet M; Nussberger J; Biollaz J; Gomez H; Callahan L; Waeber B; Brunner HR Fundam Clin Pharmacol; 1988; 2(5):413-29. PubMed ID: 2976727 [TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular ANP(1-28) has no obvious effects on renal blood flow and function in conscious sheep. Gunnarsson U Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):189-94. PubMed ID: 8076420 [TBL] [Abstract][Full Text] [Related]
15. Renal responsiveness to aldosterone during exposure to simulated microgravity. Convertino VA; Luetkemeier MJ; Elliott JJ; Ludwig DA; Wade CE J Appl Physiol (1985); 2000 Nov; 89(5):1737-43. PubMed ID: 11053320 [TBL] [Abstract][Full Text] [Related]
16. Normotensive sodium loading in normal man: regulation of renin secretion during beta-receptor blockade. Mølstrøm S; Larsen NH; Simonsen JA; Washington R; Bie P Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R436-45. PubMed ID: 19073901 [TBL] [Abstract][Full Text] [Related]
17. Effect of vasopressin on cardiovascular and renal functions and ANP release under plasma volume expansion. Ohta M; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Yamamoto T; Yoshinaga K Tohoku J Exp Med; 1991 Oct; 165(2):115-29. PubMed ID: 1839872 [TBL] [Abstract][Full Text] [Related]
18. Effects of endothelin-induced nitric oxide on venous circulation and renal water-electrolyte handling. Ota K; Kimura T; Shoji M; Ota M; Funyu T; Mori T; Sahata T J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S128-32. PubMed ID: 9595420 [TBL] [Abstract][Full Text] [Related]
19. Modification of atrial natriuretic peptide system in cold-induced hypertensive rats. Yuan K; Jin X; Park WH; Kim JH; Park BH; Kim SH Regul Pept; 2009 Apr; 154(1-3):112-20. PubMed ID: 19254746 [TBL] [Abstract][Full Text] [Related]
20. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin. Abu-Amarah I; Balment RJ Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]